CD8A and neoplasm: This prime/boost strategy effectively delayed tumour growth following TRAMP C-1 tumour challenge, however, only high levels of mSTEAP-specific CD8+ T cells were found in the blood and spleens indicating that the anti-tumour effect was predominantly due to mSTEAP vaccination.